Trials / Withdrawn
WithdrawnNCT05101330
Impact of Bilingual Prescription Medication Labels Among Elderly Singaporeans
Impact of Bilingual Prescription Medication Labels on Medication Adherence and Medication Management Self-Efficacy Among Elderly Singaporeans: A Pilot Study
- Status
- Withdrawn
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 0 (actual)
- Sponsor
- Singapore General Hospital · Academic / Other
- Sex
- All
- Age
- 50 Years
- Healthy volunteers
- Not accepted
Summary
The proposed study aims to provide preliminary data that will enable the conduct of a larger Randomized Controlled Trial (RCT) on the impact of bilingual Prescription Medication Labels (PMLs) on 3 medication-related outcomes - medication adherence, medication management self-efficacy, and PML understanding.
Detailed description
The investigators will randomize 40 patients to Pilot Trial A or Pilot Trial B. Those in Pilot Trial A will be further randomized to Bilingual PMLs (intervention arm) or English PMLs (usual care arm) at 2 weeks post-recruitment, after assessing baseline level of the 3 medication-related outcomes; trial outcomes: difference in change, from baseline to 2 weeks post-randomization, in the 3 medication-related outcomes between the 2 arms. Those in Pilot Trial B will be further randomized to Bilingual PMLs or English PMLs immediately post-recruitment; trial outcomes: difference, at 2 weeks post-randomization, in the 3 medication-related outcomes between the 2 arms. This formative study will (1) assess the feasibility of administering the intervention, (2) refine protocols for study participant recruitment, engagement and retention, and (3) gain experience with and refine measurement of the outcomes for evaluating the intervention. The conduct of 2 pilot trials will allow us to choose the optimal trial design and determine variability.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Bilingual prescription medication labels | The bilingual PML contains English and Chinese medication-related instructions for participants. |
Timeline
- Start date
- 2021-11-01
- Primary completion
- 2022-05-12
- Completion
- 2022-05-12
- First posted
- 2021-11-01
- Last updated
- 2022-05-24
Locations
1 site across 1 country: Singapore
Source: ClinicalTrials.gov record NCT05101330. Inclusion in this directory is not an endorsement.